Drug intelligence / Profile preview

Zhu-Bai formula

Development stage
Unknown
Lead developer
Liaoning University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Zhu-Bai formula is a Traditional Chinese Medicine (TCM) polyherbal formulation specifically developed for the treatment of **Henoch-Schönlein purpura nephritis (HSPN)** and **IgA nephropathy**, particularly targeting the **Wet-Heat (Shi-Re)** syndrome. The formula is composed of ten primary herbal ingredients: *Smilax glabra* (Glabrous Greenbrier Rhizome), *Atractylodes chinensis* (Chinese Atractylodes Rhizome), *Phellodendron amurense* (Amur Corktree Bark), *Leontopodium leontopodioides* (Common Edelweiss herb), *Cirsium setosum* (Field Thistle), *Imperata cylindrica* (Lalang Grass Rhizome), *Sanguisorba officinalis* (Garden Burnet Root), *Typha angustifolia* (Cattail Pollen), *Rehmannia glutinosa* (Rehmannia Root), and *Angelica sinensis* (Chinese Angelica Root). Its pharmacological profile is characterized by anti-inflammatory, hemostatic, and immunomodulatory activities. It aims to clear heat, resolve dampness, and cool the blood to prevent vascular leakage and hematuria. Clinically, it has been evaluated in large-scale multicenter trials to assess its efficacy in reducing proteinuria and urinary erythrocytes in pediatric patients, often as an adjunct to conventional ACE inhibitors or corticosteroid therapy.

Other names
Zhu-Bai-FangZhu-Bai granulesZhubaifang
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)NF-κBIL1A (Interleukin 1 alpha)

Beyond the preview

Go deeper on Zhu-Bai formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhu-Bai formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call